These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12699069)

  • 1. Chemoprevention of colorectal cancer.
    Biasco G; Di Marco M; Pantaleo MA
    Int J Biol Markers; 2003; 18(1):75-7. PubMed ID: 12699069
    [No Abstract]   [Full Text] [Related]  

  • 2. Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric and colorectal cancer.
    Zeybek U; Yaylim I; Yilmaz H; Ağaçhan B; Ergen A; Arikan S; Bayrak S; Isbir T
    Cell Biochem Funct; 2007; 25(4):419-22. PubMed ID: 16927418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy in females.
    Paré L; Salazar J; del Rio E; Baiget M; Altés A; Marcuello E; Paez D; Barnadas A
    J Clin Oncol; 2008 Jul; 26(20):3468; author reply 3468-9. PubMed ID: 18612168
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential roles of genetic biomarkers in colorectal cancer chemoprevention.
    Syngal S; Clarke G; Bandipalliam P
    J Cell Biochem Suppl; 2000; 34():28-34. PubMed ID: 10762012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer.
    Ma J; Stampfer MJ; Giovannucci E; Artigas C; Hunter DJ; Fuchs C; Willett WC; Selhub J; Hennekens CH; Rozen R
    Cancer Res; 1997 Mar; 57(6):1098-102. PubMed ID: 9067278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can statins pass the aspirin litmus test in cancer?
    Kauh J; Khuri FR
    J Clin Oncol; 2007 Aug; 25(23):3395-6. PubMed ID: 17687147
    [No Abstract]   [Full Text] [Related]  

  • 7. Methylenetetrahydrofolate reductase polymorphism in advanced colorectal cancer: a novel genomic predictor of clinical response to fluoropyrimidine-based chemotherapy.
    Cohen V; Panet-Raymond V; Sabbaghian N; Morin I; Batist G; Rozen R
    Clin Cancer Res; 2003 May; 9(5):1611-5. PubMed ID: 12738713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of colorectal cancer associated with the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in the Kashmiri population.
    Sameer AS; Shah ZA; Nissar S; Mudassar S; Siddiqi MA
    Genet Mol Res; 2011 Jun; 10(2):1200-10. PubMed ID: 21732284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention of cancer.
    Tsao AS; Kim ES; Hong WK
    CA Cancer J Clin; 2004; 54(3):150-80. PubMed ID: 15195789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General keynote: the impact of cancer chemoprevention.
    Hong WK
    Gynecol Oncol; 2003 Jan; 88(1 Pt 2):S56-8. PubMed ID: 12586087
    [No Abstract]   [Full Text] [Related]  

  • 11. Methylenetetrahydrofolate reductase polymorphism and risk of colorectal adenomas.
    Marugame T; Tsuji E; Inoue H; Shinomiya S; Kiyohara C; Onuma K; Hamada H; Koga H; Handa K; Hayabuchi H; Kono S
    Cancer Lett; 2000 Apr; 151(2):181-6. PubMed ID: 10738112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interactive effect of methyl-group diet and polymorphism of methylenetetrahydrofolate reductase on the risk of colorectal cancer.
    Kim DH
    Mutat Res; 2007 Sep; 622(1-2):14-8. PubMed ID: 17602711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic folate status and risk of colorectal cancer.
    Brockton NT
    Cancer Causes Control; 2008 Nov; 19(9):1005-7; author reply 1003. PubMed ID: 18438717
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic polymorphisms of methylenetetrahydrofolate reductase and colorectal cancer and adenoma.
    Kono S; Chen K
    Cancer Sci; 2005 Sep; 96(9):535-42. PubMed ID: 16128738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stats on statins: anything but static.
    McLaughlin J
    J Natl Cancer Inst; 2006 Jan; 98(1):4-5. PubMed ID: 16391362
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter to the editor: a meta-analyses of association between polymorphism of MTHFR A1298C and colorectal cancer risk.
    Ge H; Zheng X; Zhao E; Sheng X; Lu S; Cheng S; Yu J
    Int J Colorectal Dis; 2012 Oct; 27(10):1387-8. PubMed ID: 22350268
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemoprevention of colorectal cancer.
    Svec J
    Bratisl Lek Listy; 2005; 106(6-7):238-9. PubMed ID: 16201746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The folate pool in colorectal cancers is associated with DNA hypermethylation and with a polymorphism in methylenetetrahydrofolate reductase.
    Kawakami K; Ruszkiewicz A; Bennett G; Moore J; Watanabe G; Iacopetta B
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5860-5. PubMed ID: 14676107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemoprevention of colorectal cancer for broad clinical use in the future].
    Mutoh M; Ishikawa H; Wakabayashi K
    Gan To Kagaku Ryoho; 2015 May; 42(5):534-7. PubMed ID: 25981646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of the methylenetetrahydrofolate reductase C677T polymorphism with microsatellite instability and promoter hypermethylation in sporadic colorectal cancer.
    Clarizia AD; Bastos-Rodrigues L; Pena HB; Anacleto C; Rossi B; Soares FA; Lopes A; Rocha JC; Caballero O; Camargo A; Simpson AJ; Pena SD
    Genet Mol Res; 2006 Jun; 5(2):315-22. PubMed ID: 16819711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.